Description |
calcium voltage-gated channel auxiliary subunit beta 2 |
G protein-coupled receptor 85 |
Image |
No pdb structure |
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Antisaccade task score ( 31596458)
- Apolipoprotein B levels ( 32203549)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
- Blood pressure ( 21909110)
- Body mass index ( 28892062)
- Brain volume in infants (grey matter) ( 28763065)
- Cadmium levels ( 26025379)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Diastolic blood pressure ( 19430479 27841878 21909115 28739976 27618452)
- Diastolic blood pressure (cigarette smoking interaction) ( 29455858)
- Diastolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- Diverticular disease ( 30177863)
- Electrocardiogram morphology (amplitude at temporal datapoints) ( 32916098)
- Hypertension ( 31879980 19430479 21909115)
- LDL cholesterol levels ( 32203549)
- Mean arterial pressure ( 27618448)
- Mean arterial pressure x alcohol consumption interaction (2df test) ( 29912962)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (beta blocking agents) ( 31015401)
- Medication use (calcium channel blockers) ( 31015401)
- Medication use (diuretics) ( 31015401)
- Metabolite levels (HVA/MHPG ratio) ( 23319000)
- Nicotine dependence symptom count ( 25555482)
- Obesity-related traits ( 23251661)
- Primary tooth development (number of teeth) ( 23704328)
- Primary tooth development (time to first tooth eruption) ( 23704328)
- Protein quantitative trait loci ( 18464913)
- Pulse pressure ( 30578418)
- Pulse pressure x alcohol consumption interaction (2df test) ( 29912962)
- Quantitative traits ( 19197348)
- Response to antiepileptic drugs in genetic generalized epilepsy ( 32308125)
- Schizophrenia ( 28991256 25056061 29483656 30285260 23974872)
- Small vessel stroke ( 26732560)
- Systolic blood pressure ( 28135244 19430479 27841878 21909115 28739976 27618452 30578418)
- Systolic blood pressure (cigarette smoking interaction) ( 29455858)
- Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
- Systolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- White matter hyperintensity volume ( 33293549)
|
- Attention deficit hyperactivity disorder and conduct disorder ( 18951430)
- Triglycerides ( 25961943)
|
Interacting Genes |
13 interacting genes:
C10orf67
CTBP2
GPR85
HEXIM2
MSRB2
NEBL
NRP1
PDIA3
PRKACA
PRMT5
PTER
REM1
TMEM174
|
3 interacting genes:
CACNB2
CXCL14
FOXP2
|
Entrez ID |
783 |
54329 |
HPRD ID |
02473 |
05543 |
Ensembl ID |
ENSG00000165995
|
ENSG00000164604
|
Uniprot IDs |
A0A494C0B2
A0A494C184
Q08289
Q59H42
Q5VVH1
|
A4D0T8
P60893
Q8NEN2
|
PDB IDs |
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|